Genetic depletion of AQP4 in mice has been shown to elicit a substantial reduction of the clearance of proteins like amyloid β and phosphorylated tau, thus contributing to their accumulation and deposition in the brain, proposed key steps in the pathogenesis of Alzheimer’s and Parkinson’s diseases, respectively (17, 18). This evidence concerns the gene MAPT and Parkinson disease.